Tag Archives: Pfizer

‘Let’s Do Insulin Next,’ Says Ocasio-Cortez After Biden Backs IP Waiver to Boost Covid-19 Vaccine Access

“We can do it with all lifesaving pharmaceuticals,” tweeted one group.

By Jessica Corbett, staff writer for Common Dreams. Published 5-5-2021

After the Biden administration on Wednesday caved to global pressure and endorsed waiving intellectual property protections for Covid-19 vaccines, progressives across the United States called for taking a similar approach to other lifesaving drugs and treatments made less accessible by Big Pharma’s greed.

“Let’s do insulin next,” tweeted Rep. Alexandria Ocasio-Cortez (D-N.Y.), a self-described “unapologetic advocate of Medicare for All” who also “believes that all people must have access to safe and affordable prescription medications.” Continue reading

Share Button

200+ Groups From 67 Nations Demand ‘Transformational Change’ at Corporate-Friendly WTO

“The WTO’s hyperglobalization rules shaped a global economy that is not working for most people, and it’s due time to replace them.”

By Jake Johnson, staff writer for Common Dreams. Published 4-28-2021

WTO Headquarters. Screenshot: Sky News

More than 200 environmental groups, labor unions, and civil society organizations from 67 nations sent a letter to global heads of state on Wednesday demanding “transformational change” at the World Trade Organization, a relatively new institution that critics say is structurally inadequate and much too corporate-friendly to confront the planet’s most pressing challenges.

“The Covid-19 pandemic has exposed how the WTO model exacerbates insecurity, inequality, and instability,” argues the coalition, which includes Public Services International, Third World Network-Africa, and Public Citizen. “Legitimate global commercial rules should facilitate the improvement of the livelihoods, health, and wellbeing of all people around the world and the long-term survival of the planet. The WTO system has not met these goals: It was never fit for purpose and certainly is not now.” Continue reading

Share Button

Pressure Campaign Kicks Off in US to Force Big Pharma and Biden to End Vaccine Apartheid

The absence of a WTO patent waiver, say public health advocates, “means we won’t end the pandemic, millions of people will die, and the global economy will suffer.”

By Kenny Stancil, staff writer for Common Dreams. Published 4-22-2021

“Pfizer has spent the past year making billions of dollars in profits while people continue to die from Covid-19,” tweeted Health GAP on April 22, 2021. “It’s time to #FreeTheVaccine so the whole world has access to these life-saving vaccines!” (Photo: Twitter screengrab via Health GAP)

As vast global inequalities in access to Covid-19 vaccines exacerbate the ongoing pandemic, a coalition of progressive groups in the U.S. kicked off a week of action Thursday to urge President Joe Biden to support a temporary suspension of patent protections and to pressure pharmaceutical corporations to share technology in order to maximize the worldwide production of life-saving doses.

In the coming days, public health campaigners will gather at the headquarters of Pfizer, Moderna, and Johnson & Johnson in an attempt to push the major drugmakers to share relevant technology through the World Health Organization’s Covid-19 Technology Access Pool. Continue reading

Share Button

As Rich Countries Shield Pharma Monopolies, Just 0.2% of Covid Vaccine Doses Have Gone to Poor Nations

“We need the cooperation of the whole world and the elimination of all the barriers to the production and distribution of vaccines.”

By Jake Johnson, staff writer for Common Dreams. Published 4-11-2021

Graphic: Our World in Data/CC

The head of the World Health Organization estimated in a recent address that of the more than 700 million coronavirus vaccine doses that have been administered across the globe, just 0.2% have gone to people in low-income nations—inequity that experts warn will persist unless rich countries end their obstruction of an international effort to suspend vaccine patents.

Speaking to the media on Friday, WHO Director General Tedros Adhanom Ghebreysus warned that “there remains a shocking imbalance in the global distribution of vaccines” as pharmaceutical companies cling to their monopoly control over technology that was developed with large infusions of public money. Continue reading

Share Button

The Coming Antibiotic-Resistance Pandemic that Could Make COVID Look Like the Flu

While the Global South overprescribes antibiotics, in the West farm animals are pumped full of them, farmers even giving them to healthy animals so they can be packed tighter in ever-increasing herd sizes.

By Alan Macleod  Published 4-6-2021 by MintPress News

Photo: Gerard D Wright/CC

Big pharmaceutical companies have not come out of COVID-19 looking like model global citizens. Pfizer has been accused of bullying South American governments after demanding they put up military bases as collateral in exchange for vaccines. Meanwhile, Bill Gates persuaded Oxford University to sign an exclusive deal with AstraZeneca for its new offering, rather than allow it to be copied freely by all. The British/Swedish multinational quickly announced it would fall 50 million vaccines short on its first shipment to the European Union.

But what if there were a looming health crisis that could make COVID look almost minor in comparison? The World Health Organization (WHO) has been warning of just such a case for some time now, predicting that antimicrobial resistance will kill up to 10 million people every year by 2050 — almost four times as many as the coronavirus has killed in the past 12 months. Continue reading

Share Button

Big Pharma Quietly Planning Price Hike for Covid Vaccines in ‘Near Future’: Report

“As this shifts from pandemic to endemic, we think there’s an opportunity here for us,” said Pfizer’s Chief Financial Officer Frank D’Amelio.

By Kenny Stancil, staff writer for Common Dreams. Published 3-19-2021

Photo: KALW/CC

Eager to capitalize on the lasting presence of the coronavirus, executives at Johnson & Johnson, Moderna, and Pfizer—the pharmaceutical corporations that supplied the Covid-19 vaccines approved for use in the U.S.—are quietly planning to hike prices on doses “in the near future,” once they decide the pandemic is over, The Intercept’s Lee Fang reported Thursday.

Although the rapid development of coronavirus vaccines—made possible by large infusions of public resources—has given Big Pharma companies “a boost in goodwill… the public is still sensitive to drug pricing and the reputational risk has, so far, curtailed their ability to reap large financial rewards,” Fang noted. “But that environment, they hope, will change once the pandemic ends: a date that drugmakers themselves reserve the right to declare.” Continue reading

Share Button

Promised Vaccine Stockpile Doesn’t Even Exist? Governors Demand Trump ‘Answer Immediately for This Deception’

States “thought they were getting more doses and they planned for more doses and opened up to 65 and up, thinking they were getting more.”

By Kenny Stancil, staff writer for Common Dreams. Published 1-15-2021

Earlier this week, the White House said the federal government would soon release coronavirus vaccine doses stored for second shots, but governors expecting increased shipments discovered Friday that no national stockpile exists, and now they are demanding that President Donald Trump’s administration be held accountable for deceiving the American public.

“Governors were told repeatedly by [the Department of Health and Human Services] there was a strategic reserve of vaccines, and this week, the American people were told it’d be released to increase supply of vaccine,” tweeted Washington Gov. Jay Inslee (D) on Friday. “It appears now that no reserve exists. The Trump admin. must answer immediately for this deception.” Continue reading

Share Button

‘What a Failed State Looks Like’: GOP Under Fire for Blocking Necessary Funds as Covid Vaccine Distribution Begins

“The end of a tragic, crippling pandemic is in sight and Senate Republicans can’t get around to authorizing any money to complete the job.”

By Jake Johnson, staff writer for Common Dreams. Published 12-14-2020

Margaret Klessens, a 96-year-old World War II veteran, gets the COVID vaccine in Massachusetts. Photo: Dr. Sanjay Gupta/Twitter

As U.S. distribution of the newly approved Pfizer-BioNTech coronavirus vaccine kicked off Sunday with the shipment of millions of doses to sites across the nation, Senate Republicans faced mounting outrage for continuing to block federal funds that crisis-ravaged states and localities desperately need to carry out an unparalleled mass inoculation effort.

Facing large budget shortfalls due to the Covid-19 pandemic and lack of relief from the deadlocked Congress, state and local governments will soon be tasked with executing a rapid vaccination campaign that will require large quantities of supplies as well as new clinics, additional workers, and public outreach—all of which will cost money that states and localities fear they don’t have. Continue reading

Share Button

Lawsuit by 44 States Accuses Pharma Giants of ‘Multi-Year Conspiracy’ to Hike Drug Prices by Over 1,000%

“We have hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people.”

By Jake Johnson, staff writer for Common Dreams. Published 5-12-2019

Pfizer World Headquarters – New York City. Photo: Norbert Nagel/CC

A far-reaching lawsuit filed Friday by the attorneys general of more than 40 states accused some of the nation’s largest generic drug manufacturers of conspiring to inflate prices, in some cases by over 1,000 percent.

“We have hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people,” Connecticut Attorney General William Tong, whose state led the probe into the companies’ practices, said in a statement. Continue reading

Share Button

Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia

by Robert Faturechi ProPublica, June 1, 2017, 8 a.m.

Tom Price. Photo: Gage Skidmore [CC BY-SA 2.0], via Wikimedia Commons

In the spring before the 2016 presidential election, the Obama administration’s 12-nation trade agreement known as the Trans-Pacific Partnership, or TPP, was still alive. Negotiators worked on details as Congress considered whether to ratify the pact.

The Australian government was getting in the way of one change demanded by U.S. pharmaceutical companies. Makers of cutting-edge biological drugs wanted to have data from their clinical trials protected from competitors for 12 years, as they are under U.S. law 2014 not the roughly five years permitted under the TPP. Australian officials insisted that an extension would deprive consumers of cheaper alternatives for too long. Continue reading

Share Button